Yue Han

Yuehan Biotech is a Shanghai-based biotechnology company specializing in the development of mRNA-based therapeutics and vaccines. The company focuses on leveraging its proprietary lipid nanoparticle (LNP) delivery technology to address challenges in drug stability and targeted delivery. Yuehan's research and development efforts span across infectious diseases, oncology, and rare genetic disorders. By integrating advanced molecular biology with innovative delivery systems, the company aims to create a robust pipeline of next-generation genetic medicines. Yuehan Biotech is positioned as a platform-driven entity, seeking to advance its internal programs while exploring strategic collaborations within the global life sciences sector.